search
Back to results

Peripheral Perfusion Targeted Fluid Management

Primary Purpose

Sepsis, Severe Sepsis

Status
Unknown status
Phase
Phase 4
Locations
Netherlands
Study Type
Interventional
Intervention
PPTFM
Sponsored by
Erasmus Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Sepsis focused on measuring peripheral perfusion, critically ill patients, fluid administration

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • All adult patients (>18 years) admitted to the intensive care with 1) hemodynamic instability due to severe sepsis, and 2) a mean arterial pressure < 65 mmHg and 3) an arterial lactate concentration > 3.0 mmol/L will be considered for participation

Exclusion Criteria:

  • moribund.
  • severe coagulation disorder (contraindication for central venous catheter placement).
  • severe peripheral vascular disease (interfering with peripheral perfusion measurement).

Sites / Locations

  • ErasmusMCRecruiting
  • ErasmusMCRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control

PPTFM

Arm Description

The fluid management algorithm of the control group is based on the standard care procedure of our ICU as recommended in guidelines: the patient's fluid status is assessed by performing a fluid challenge with a bolus of 250 ml colloids. When the patients is fluid responsive (i.e. showing an increase in stroke volume > 10% ) he will receive an additional bolus of 250 ml of colloids. After each fluid challenge, patients will be revaluated for fluid responsiveness to access need of further fluid administration.

The fluid management algorithm of the intervention group uses identical therapy (i.e. fluids) yet targeted at different endpoints (i.e. peripheral perfusion parameters). After evaluation of peripheral perfusion, only patients with a "bad peripheral perfusion" (i.e. 3 out of 4 criteria considered as bad) will receive a fluid challenge, the same way as in the standard care procedure (i.e. bolus of 250 ml of fluid). After each fluid challenge, patients will be re-evaluated for peripheral perfusion to access further need in fluid challenges. To ensure that no hypovolemia will occur in the intervention group, fluid will be administered irrespectively of peripheral perfusion parameters, if cardiac index falls below a value of 2,5 L/min/m2.

Outcomes

Primary Outcome Measures

Fluid balance during Intensive Care Unit stay
Total and daily fuid balance for a maximal time period of 72 hours

Secondary Outcome Measures

CRT (Capillary refill time)
Parameter of peripheral perfusion
Systemic hemodynamic variables
Heart Rate Mean Arterial Pressure Cardiac Index Cardiac output Stroke Volume Central Venous Pressure Systemic Vascular Resistance
Respiratory function
FiO2 PEEP Breathing Frequency pCO2 pO2
PFI (Peripheral Flow Index)
Parameter of peripheral perfusion
Tskindiff (Forearm-to-Fingertip temperature skin difference)
Parameter of peripheral perfusion
StO2 (Peripheral tissue oxygenation)
Parameter of peripheral perfusion

Full Information

First Posted
July 7, 2011
Last Updated
January 3, 2014
Sponsor
Erasmus Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT01397474
Brief Title
Peripheral Perfusion Targeted Fluid Management
Official Title
Peripheral Perfusion Targeted Fluid Management in Critically Ill Patients: a Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
January 2014
Overall Recruitment Status
Unknown status
Study Start Date
October 2011 (undefined)
Primary Completion Date
January 2014 (Anticipated)
Study Completion Date
January 2014 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Erasmus Medical Center

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Impaired peripheral perfusion is related to worse outcome in critically ill patients. Although this is known, these parameters have never been used as target for hemodynamic therapy. We hypothesize that targeting of fluid administration on parameters of peripheral perfusion might prevent excessive fluid administration, leading to less formation of tissue edema, less respiratory dysfunction and shorter duration of mechanical ventilation in critically ill patients.
Detailed Description
Rationale: Currently, fluid administration of critically ill patients is aimed at optimizing conventional hemodynamic parameters such as stroke volume and cardiac output. Fluid is infused repeatedly until patients become "non-responsive", i.e. cardiac output does not increase anymore. However, the ultimate goal of hemodynamic therapy should be to improve peripheral (i.e. tissue) perfusion. Recently we have shown that 1) increasing stroke volume does not always have an effect on peripheral perfusion and 2) that peripheral perfusion is not impaired when stroke volume can still be increased with fluid infusion. Furthermore, repeated administration of fluid in order to reach a maximum cardiac output can lead to an enormous accumulation of fluid in the patient. This leads to formation of lung edema and respiratory dysfunction and is associated with prolonged mechanical ventilation and ICU-stay. Recently, techniques have been developed which allow bedside assessment of peripheral perfusion. Although impaired peripheral perfusion was related to worse outcome, these parameters have never been used as target for hemodynamic therapy. Objective: To study whether peripheral perfusion targeted fluid management (PPTFM) leads to less fluid administration, improved respiratory function and shorter mechanical ventilation. Study design: The study is a pilot study and is designed as a randomized controlled trial. The study will be conducted as a single-center study at the Intensive Care of the Erasmus Medical Center. Study population: We aim to include 40 adult patients who are admitted to the Intensive Care with hemodynamic instability (defined as mean arterial pressure < 65 mmHg and an arterial lactate concentration > 3.0 mmol/l) due to severe sepsis and septic shock. Intervention: In the intervention group fluid management is targeted on peripheral perfusion parameters while in the control group fluid is administered in order to optimize cardiac output. Main study parameters/endpoints: The main study endpoints are daily fluid balance and duration of mechanical ventilation. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: There is a possible risk that in the treatment group the patients will remain hypovolemic. To ensure that this will not occur, fluids will be administrated in this group, irrespective of peripheral perfusion parameters, until cardiac index is 2,5 L/min/m2. Assessment of peripheral perfusion is performed with non-invasive optical techniques that impose no burden to the patient.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sepsis, Severe Sepsis
Keywords
peripheral perfusion, critically ill patients, fluid administration

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
The fluid management algorithm of the control group is based on the standard care procedure of our ICU as recommended in guidelines: the patient's fluid status is assessed by performing a fluid challenge with a bolus of 250 ml colloids. When the patients is fluid responsive (i.e. showing an increase in stroke volume > 10% ) he will receive an additional bolus of 250 ml of colloids. After each fluid challenge, patients will be revaluated for fluid responsiveness to access need of further fluid administration.
Arm Title
PPTFM
Arm Type
Experimental
Arm Description
The fluid management algorithm of the intervention group uses identical therapy (i.e. fluids) yet targeted at different endpoints (i.e. peripheral perfusion parameters). After evaluation of peripheral perfusion, only patients with a "bad peripheral perfusion" (i.e. 3 out of 4 criteria considered as bad) will receive a fluid challenge, the same way as in the standard care procedure (i.e. bolus of 250 ml of fluid). After each fluid challenge, patients will be re-evaluated for peripheral perfusion to access further need in fluid challenges. To ensure that no hypovolemia will occur in the intervention group, fluid will be administered irrespectively of peripheral perfusion parameters, if cardiac index falls below a value of 2,5 L/min/m2.
Intervention Type
Other
Intervention Name(s)
PPTFM
Other Intervention Name(s)
CRT, PFI, delta Temp, StO2
Intervention Description
Peripheral Perfusion Targeted Fluid Management
Primary Outcome Measure Information:
Title
Fluid balance during Intensive Care Unit stay
Description
Total and daily fuid balance for a maximal time period of 72 hours
Time Frame
untill 72 hours after admission
Secondary Outcome Measure Information:
Title
CRT (Capillary refill time)
Description
Parameter of peripheral perfusion
Time Frame
Within 72 hours after admission
Title
Systemic hemodynamic variables
Description
Heart Rate Mean Arterial Pressure Cardiac Index Cardiac output Stroke Volume Central Venous Pressure Systemic Vascular Resistance
Time Frame
Untill 72 hours after admission to the ICU
Title
Respiratory function
Description
FiO2 PEEP Breathing Frequency pCO2 pO2
Time Frame
Untill 72 hours after admission to the ICU
Title
PFI (Peripheral Flow Index)
Description
Parameter of peripheral perfusion
Time Frame
Untill 72 hours after ICU admission
Title
Tskindiff (Forearm-to-Fingertip temperature skin difference)
Description
Parameter of peripheral perfusion
Time Frame
Untill 72 hours after ICU admission
Title
StO2 (Peripheral tissue oxygenation)
Description
Parameter of peripheral perfusion
Time Frame
Untill 72 hours after ICU admission

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All adult patients (>18 years) admitted to the intensive care with 1) hemodynamic instability due to severe sepsis, and 2) a mean arterial pressure < 65 mmHg and 3) an arterial lactate concentration > 3.0 mmol/L will be considered for participation Exclusion Criteria: moribund. severe coagulation disorder (contraindication for central venous catheter placement). severe peripheral vascular disease (interfering with peripheral perfusion measurement).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jasper Bommel, MD, PhD
Phone
003110704 0704
Email
j.vanbommel@erasmusmc.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jasper van Bommel, MD, PhD
Organizational Affiliation
Erasmus Medical Center
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Michel E Genderen, Drs
Organizational Affiliation
Erasmus Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
ErasmusMC
City
Rotterdam
State/Province
Zuid-Holland
ZIP/Postal Code
3015 CE Rotterdam
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jasper van Bommel, MD,PhD
Phone
0031107040704
Email
j.vanbommel@erasmusmc.nl
First Name & Middle Initial & Last Name & Degree
Jasper van Bommel, MD, PhD
First Name & Middle Initial & Last Name & Degree
Alex P Lima, MD
First Name & Middle Initial & Last Name & Degree
Michel E van Genderen, Drs
First Name & Middle Initial & Last Name & Degree
Sophie Nebout, MD
Facility Name
ErasmusMC
City
Rotterdam
State/Province
Zuid-Holland
ZIP/Postal Code
3015 CE Rotterdam
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jasper v Bommel, MD,PhD
Email
j.vanbommel@erasmusmc.nl
First Name & Middle Initial & Last Name & Degree
Jasper v Bommel, MD,PhD
First Name & Middle Initial & Last Name & Degree
Michel v Genderen, Msc

12. IPD Sharing Statement

Citations:
PubMed Identifier
19237899
Citation
Lima A, Jansen TC, van Bommel J, Ince C, Bakker J. The prognostic value of the subjective assessment of peripheral perfusion in critically ill patients. Crit Care Med. 2009 Mar;37(3):934-8. doi: 10.1097/CCM.0b013e31819869db.
Results Reference
background
PubMed Identifier
21685739
Citation
Lima A, van Bommel J, Sikorska K, van Genderen M, Klijn E, Lesaffre E, Ince C, Bakker J. The relation of near-infrared spectroscopy with changes in peripheral circulation in critically ill patients. Crit Care Med. 2011 Jul;39(7):1649-54. doi: 10.1097/CCM.0b013e3182186675.
Results Reference
background
PubMed Identifier
25679107
Citation
van Genderen ME, Engels N, van der Valk RJ, Lima A, Klijn E, Bakker J, van Bommel J. Early peripheral perfusion-guided fluid therapy in patients with septic shock. Am J Respir Crit Care Med. 2015 Feb 15;191(4):477-80. doi: 10.1164/rccm.201408-1575LE. No abstract available.
Results Reference
derived

Learn more about this trial

Peripheral Perfusion Targeted Fluid Management

We'll reach out to this number within 24 hrs